A 2x2 Factorial Randomized Phase III Study of Intermittent Oral Capecitabine in Combination With Intravenous Oxaliplatin (Q3W) ("XELOX") with/without Intravenous Bevacizumab (Q3W) versus Bolus and Continuous Infusion

  • DeSimone, Philip (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date5/1/03 → 3/31/07